COMING SOON: Alpha-1 antitrypsin deficiency (PiZZ)

Clinics: Greater Manchester Late Phase, Merseyside, South Yorkshire, West Yorkshire

Therapy Area: Alpha-1 antitrypsin deficiency (PiZZ)

Gender and Age: Males & Females aged 18 – 75

Reimbursement: £TBC

Alpha-1 antitriptysin deficiency

About The Research...

Alpha-1 antitrypsin deficiency (AATD) is a rare, inherited genetic condition which can cause life threatening respiratory or liver problems and occurs in people in different types: ZZ, SZ or MZ. MAC Clinical Research are privileged to soon be recruiting for a new clinical trial for patients with AATD of the ZZ variety. British Lung Foundation estimate around 12,000 people are living with AATD (ZZ) in the UK at the moment. If you, or a loved one, are over 18 and one of these 12,000 then we would love to hear from you if you are interested in this upcoming study.

More information will be available on the trial once approval of the study is granted by the regulatory bodies in the UK.

Key Inclusion Criteria


Key Exclusion Criteria


MAC Clinical Research is currently conducting a new clinical research study for people with Alpha-1 antitrypsin deficiency (PiZZ).

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Share on twitter
Share on whatsapp
Share on email